Small Cap Biopharmas Omeros, Geron, Jump in Early Trading

Joel Anderson |

The healthcare sector saw a major bump for two small cap biopharmaceutical companies today, both building on major gains from last week. Omeros Corp. (OMER) shot up over 35 percent, continuing a run that’s seen the company’s shares jump almost 85 percent since last Monday. Joining Omeros was Geron Corporation (GERN) , which was up over 20 percent in early trading and has more than doubled its share price this month.



Omeros corporation’s strong Monday comes one week after it shot up 68.17 percent in on day on an upgrade from Wedbush that increased its price target to $28, a price that would represent a 460 percent jump from its closing price the Friday prior. Wedbush analyst Liana Moussatos cited eye-surgery drug OMS302 as the primary reason for her improved outlook on Omeros, but the company also announced Thursday that it was initiating a new mid-stage trial for its schizophrenia drug OMS824. Today’s gains pushed Omeros past resistance, showing considerable optimism for the company on the part of investors.

On Sept. 11 Geron President and CEO John Scarlett, M.D., presented at the Stifel conference, and it must have been one great presentation, because shares are up over 80 percent since then. A deeper look, though, may reveal that Geron’s recent gains come off of optimism on the part of investors because of action on the options market. The day after the presentation at the Stifel conference, 10,000 put options were sold with a strike price of $2, which could have sparked the increased interest by those traders who closely watch the options market. Geron currently has one phase-2 drug clinical trial currently in motion for its drug imetelstat. This study is focused on imetelstat as a treatment for essential thrombocythemia or polycythemia vera.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
GERN Geron Corporation 2.28 0.00 0.00 1,775,561
OMER Omeros Corporation 11.02 -0.07 -0.63 307,881
FPGR FP Group Ltd. n/a n/a n/a 0

Comments

Emerging Growth

Winston Gold Mining Corp.

Winston Gold Mining Corp is a mineral exploration and development company. The Company is engaged in acquiring, exploring, developing, and operating mining properties.

Private Markets

Cross Campus

With over 500 members and operating 80,000 square feet by summer 2016, Cross Campus is one of the country’s top ten shared, collaborative office or "coworking" operators in the US.…

GoCoin

Blockchain currencies (e.g. Bitcoin) provide a new disruptive way to transfer value between parties over the internet as opposed to going through banks. GoCoin provides online merchants with a suite…